Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.05
Delayed Data
As of Feb 27
 -0.04 / -3.67%
Today’s Change
0.73
Today|||52-Week Range
1.66
+6.16%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.09
Today’s open1.08
Day’s range1.04 - 1.09
Volume159,388
Average volume (3 months)196,910
Market cap$46.3M
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio1.6
Price/Sales1.47
Price/Book8.81

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...+0.01+4.29%
ORMPOramed Pharmaceutica...+0.03+0.67%
OGXIOncoGenex Pharmaceut...+0.00+0.22%
ONTXOnconova Therapeutic...-0.01-0.43%
Data as of 4:00pm ET, 02/27/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account